Prescription Required
Zoryl-M Forte 2/1000 mg Tablet is a combination oral anti-diabetic medication used to manage Type 2 Diabetes Mellitus in adults. It contains Glimepiride (2 mg) and Metformin Hydrochloride (1000 mg), two well-known diabetes medications that work together to regulate blood sugar levels, improve insulin function, and prevent diabetes-related complications.
This medication is recommended for patients whose diabetes is not adequately controlled through diet and exercise alone. By improving insulin sensitivity and reducing excessive glucose production, Zoryl-M Forte helps maintain stable and healthy blood sugar levels.
Use with caution in liver disease; regular liver function tests are recommended.
Not suitable for severe kidney disease; requires routine kidney monitoring.
Avoid alcohol as it increases the risk of lactic acidosis and blood sugar fluctuations.
Not recommended; insulin is preferred for blood sugar control during pregnancy.
Avoid while breastfeeding, as Metformin may pass into breast milk.
Use caution, as low blood sugar may cause dizziness and affect alertness.
Its a Dual-Action Formula for Diabetes Control. Glimepiride – A sulfonylurea that stimulates the pancreas to release more insulin, helping lower blood sugar levels. Metformin – A biguanide that reduces glucose production in the liver and enhances insulin sensitivity in the body. By combining insulin stimulation and glucose regulation, this medication ensures better glycemic control throughout the day.
Type 2 diabetes occurs when the body becomes resistant to insulin or does not produce enough, leading to high blood sugar levels.
Zoryl-M Forte 2/1000 mg Tablet is a powerful dual-action diabetes medication that helps regulate blood sugar levels, enhances insulin sensitivity, and prevents complications of diabetes. It is a trusted choice for Type 2 diabetes management.
Content Updated on
Tuesday, 18 Feburary, 2025Prescription Required
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHA